The authors describe considerations and best practices for meeting drug substance uniformity.
Apr 1, 2011
By:
Sushil Abraham, Eric Rydholm, Phil Wagner
The authors describe considerations and best practices for meeting drug substance uniformity.
|
The authors present lessons learned from a case study of the transfer of a cell culture biotherapeutic process to a CMO.
Mar 2, 2011
By:
Sushil Abraham, Howard Bland
The authors present lessons learned from a case study of the transfer of a cell culture biotherapeutic process to a CMO.
|
|
